地诺单抗售价多少一盒？

In 2018, it was included in the list of overseas new drugs in urgent clinical need (first batch) and entered the rapid review channel of the State Food and Drug Administration. On May 23, 2019, China’s National Medical Products Administration announced conditional approval of the import registration application for Denosumab Injection (English name: Denosumab Injection). The drug will be used to treat adults and skeletally mature adolescent patients with unresectable giant cell tumors of bone or whose surgical resection may result in severe functional impairment.

Denosumab is a drug that targets the RANK ligand. Compared with bisphosphonates that have been used clinically, denosumab has the advantage of significantly prolonging the occurrence time of bone damage-related events. It can be administered subcutaneously in clinical practice and is easy to use. Moreover, clinical data shows that the drug does not require monitoring of renal function, while the use of bisphosphonates must be based on Monitoring of the patient's renal function determines the dosing speed; however, denosumab is currently relatively expensive, and its long-term efficacy and cost-effectiveness balance need to be further confirmed. It is expected that the specific targeting RANK ligand inhibitor denosumab can obtain more valuable research results in the treatment of solid tumors and bring new hope to patients with tumor bone metastasis.

How much does a box of denosumab cost?

Denosumab available in the United States is 60mg/1ml tube/box and priced at US$1,169.98, which is relatively expensive. Since the denosumab marketed in my country has been conditionally approved, the price is not yet clear, but the original drug is usually priced relatively high when it is marketed in my country.

Medical Travel has learned that the product produced by Amgen of the United States and marketed in Turkey is relatively cheap. The specification is 125mg/1ml tube/box, and the price is about 3,000$ equivalent to RMB. Patients in need can further contact the medical companion service to learn more about denosumab.